Drugs / PD L 506
last change Dec 2012 re-read 3 minutes ago

PD L 506

Diagnostic / imaging agent

Investigated by
photonamic GmbH & Co. KG

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01110954 May 2010 → Jul 2012 breast neoplasm photonamic GmbH & Co. KG Terminated No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PD L 506 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01110954 ↗
Modality Diagnostic / imaging agent “specific intra-operative detection of breast tumour tissue” NCT01110954 ↗